In the last trading session, 13.03 million Matinas Biopharma Holdings Inc (AMEX:MTNB) shares changed hands as the company’s beta touched 1.56. With the company’s per share price at $0.70 changed hands at $0.1 or 17.08% during last session, the market valuation stood at $3.56M. MTNB’s last price was a discount, traded about -2971.43% off its 52-week high of $21.50. The share price had its 52-week low at $0.48, which suggests the last value was 31.43% up since then. When we look at Matinas Biopharma Holdings Inc’s average trading volume, we note the 10-day average is 0.46 million shares, with the 3-month average coming to 292.89K.
Matinas Biopharma Holdings Inc (AMEX:MTNB) trade information
Instantly MTNB was in green as seen at the end of in last trading. With action -4.63%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 37.25%, with the 5-day performance at -4.63% in the red. However, in the 30-day time frame, Matinas Biopharma Holdings Inc (AMEX:MTNB) is 18.64% up. Looking at the short shares, we see there were 32365.0 shares sold at short interest cover period of 0.19 days.
Matinas Biopharma Holdings Inc (MTNB) estimates and forecasts
Year-over-year growth is forecast to reach -100.00% down from the last financial year.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 7.12%. The 2025 estimates are for Matinas Biopharma Holdings Inc earnings to increase by 26.18%.
MTNB Dividends
Matinas Biopharma Holdings Inc is expected to release its next quarterly earnings report in February.
Matinas Biopharma Holdings Inc (AMEX:MTNB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.49% of Matinas Biopharma Holdings Inc shares while 26.08% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 26.75%. There are 26.08% institutions holding the Matinas Biopharma Holdings Inc stock share, with HIGHBRIDGE CAPITAL MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 4.8971% of the shares, roughly 10.64 million MTNB shares worth $1.68 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 4.2869% or 9.32 million shares worth $1.48 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 120.41 shares estimated at $84288.0 under it, the former controlled 2.37% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.15% of the shares, roughly 58.39 shares worth around $40870.0.
